(Q35465926)

8 August 2017

Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus (English)

1 reference

8 August 2017

1 reference

1 reference

1 reference

Judith M Gottwein

2

0 references

Jens Bukh

object named as

Jens Bukh

6

0 references

Michael Houghton

3

object named as

Michael Houghton

1 reference

8 August 2017

5

Suzanne U Emerson

1 reference

8 August 2017

7

Robert H Purcell

1 reference

8 August 2017

Jean-Christophe Meunier

1

1 reference

PubMed ID

21917891

8 August 2017

Rodney S Russell

4

1 reference

PubMed ID

21917891

8 August 2017

language of work or name

English

0 references

publication date

1 October 2011

1 reference

Journal of Infectious Diseases

8 August 2017

1 reference

8 August 2017

204

1 reference

8 August 2017

8

1 reference

8 August 2017

1186-1190

1 reference

Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Characterization of the envelope glycoproteins associated with infectious hepatitis C virus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and [...]

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Vaccination of chimpanzees against infection by the hepatitis C virus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3203383

Current status of a hepatitis C vaccine: Encouraging results but significant challenges ahead

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21917891

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/INFDIS/JIR511

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

PubMed ID

21917891